Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jiawei Mojie Tablet for endometriosis-related dysmenorrhea
ChiCTR2300078100Phase 2Recruiting
- Sponsor
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
- Start
- Jul 2023
- Countries
- 1
01
Overview
Phase 2 trial of jiaweimojie in endometriosis (2 arms), sponsored by Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. Primary endpoint: Mean VAS score for dysmenorrhea after 3 treatment cycles. Started Jul 2023; status: recruiting.
02
Drugs
jiaweimojie
03
Conditions
endometriosis
Beyond the preview
Go deeper on ChiCTR2300078100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078100.